MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Pathophysiology"

  • MDS Virtual Congress 2021

    Characterization of a mouse model of PDE10A-related autosomal-dominant movement disorder.

    N. Marotta, N. Mencacci, M. Pereira Luppi, R. Awatramani, D. Krainc (Chicago, USA)

    Objective: To characterize a newly generated mouse model of the movement disorder caused by PDE10A pathogenic mutation F300L. Background: Phosphodiesterase 10A (PDE10A) is a striatal…
  • MDS Virtual Congress 2020

    The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntington’s disease pathogenesis

    S. Xu, G. Li, X. Ye, L. Ye, Z. Xu, E. Furr Stimming, S. Zhang (Houston, TX, USA)

    Objective: Huntington’s disease (HD) is caused by an abnormal expansion of a glutamine tract (polyQ) in huntingtin (HTT), a large scaffold protein with numerous reported…
  • MDS Virtual Congress 2020

    A Case of Disabling Orofacial Dyskinesias Caused by Lupus Anticoagulant

    K. Colletta, S. Kletzel (Hines, IL, USA)

    Objective: We describe a 93-year-old man with subacute, progressive onset of disabling orofacial dyskinesias (OD), found to have positive lupus anticoagulant (LA) and anti-beta2-glycoprotein IgA…
  • MDS Virtual Congress 2020

    Discharge rate dependency of bursting of pallidal neurons underlying choreic movements

    T. Hashimoto, T. Goto, K. Yoshida, L. Johnson, J. Vitek (Matsumoto, Japan)

    Objective: To investigate the physiological mechanisms of neurons in the basal ganglia motor circuit underlying choreic movements. Background: Synchronized burst discharges and the low discharge…
  • MDS Virtual Congress 2020

    Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases

    D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)

    Objective: Huntington’s Disease (HD) is a severe neurodegenerative disorder main pathogenic factor is CAG repeats in a suffered patients genome. Experimental therapy on the model…
  • MDS Virtual Congress 2020

    Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF study

    F. Rodrigues, L. Byrne, R. Tortelli, E. Johnson, P. Wijeratne, M. Arridge, E. De Vita, D. Alexander, S. Tabrizi, S. Schobel, R. Scahill, A. Heslegrave, H. Zetterberg, E. Wild (London, United Kingdom)

    Objective: To present the mutant huntingtin (mHTT) and neurofilament light (NfL) findings from the two-year prospective longitudinal HD-CSF study, in which an 80-participant cohort of…
  • MDS Virtual Congress 2020

    Evaluation of Cortical Excitability in Huntington’s Disease and Parkinson’s Disease

    N. Togashi, M. Hamada, Y. Shirota, T. Toda, K. Nishiyama, K. Hasegwa (Sagamihara, Japan)

    Objective: To evaluate the cortical excitability difference in Huntington's disease (HD) and Parkinson's disease (PD) using paired-pulse transcranial magnetic stimulation (TMS). Background: TMS is useful…
  • 2019 International Congress

    What connectivity tells us about neurodegeneration in Huntington disease? A fMRI study

    P. de Azevedo, M. Nogueira, L. Ribeiro, B. de Campos, R. Guimarães, L. Piovesana, F. Cendes, I. Lopes-Cendes, C. Yasuda (Campinas, Brazil)

    Objective: Our study investigated the impact of Huntington disease (HD) on brain connectivity, through resting-state (RS) fMRI, among the most critical regions associated with physiopathology.…
  • 2019 International Congress

    Neuromelanin MRI detects monoaminergic cell loss in Huntington Disease Expansion Gene Carriers.

    ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)

    Objective: To measure, with NM-MRI, the integrity of neuromelanin-containing monoaminergic cells in the SN and LC in Huntington Disease Gene Expansion Carriers (HDGECs) and compare…
  • 2019 International Congress

    Quantification of regional iron content with Susceptibility Weighted Imaging in Huntington Disease Expansion Gene Carriers

    ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)

    Objective: To assess brain iron content measured with SWI-MRI in HD gene expansion carriers (HDGECs). Background: Huntington’s Disease (HD) results in extensive neuronal cell loss,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley